"Clearview Cancer Institute is north Alabamas leading cancer treatment center. For over 30 years we've provided leading-edge treatment & compassion."

During the past decade, Clearview Cancer Institute conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 35 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 18 clinical trials were completed. i.e. 450% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clearview Cancer Institute" #1 sponsor was "Radiation Therapy Oncology Group" with 30 trials, followed by "Gilead Sciences" with 8 trials sponsored, "NSABP Foundation Inc" with 8 trials sponsored, "Genentech, Inc." with 5 trials sponsored and "National Cancer Institute (NCI)" with 5 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clearview Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 40 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Clearview Cancer Institute" are "Breast Cancer" (15 trials), "Chronic Lymphocytic Leukemia" (7 trials), "Head and Neck Cancer" (7 trials), "Lung Cancer" (7 trials) and "Prostate Cancer" (7 trials). Many other conditions were trialed in "Clearview Cancer Institute" in a lesser frequency.

Most popular intervention types in "Clearview Cancer Institute" are "Drug" (87 trials), "Radiation" (28 trials), "Biological" (18 trials), "Procedure" (15 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (27 trials), "Bevacizumab" (9 trials), "Rituximab" (8 trials), "conventional surgery" (8 trials) and "Idelalisib" (7 trials). Other intervention names were less common.

The vast majority of trials in "Clearview Cancer Institute" are 77 trials for "All" genders, 19 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Clearview Cancer Institute". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 76 completed trials in Clearview Cancer Institute, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Clearview Cancer Institute, 20 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".